Stay updated with breaking news from Helenm thackray. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Insider Helen M. Thackray Buys 30,000 Shares themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Trexquant Investment LP increased its position in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Rating) by 44.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 106,470 shares of the biotechnology company’s stock after acquiring an additional 32,958 shares […] ....
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock. ....
Equities research analysts predict that BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Rating) will post $63.92 million in sales for the current quarter, according to Zacks. Five analysts have made estimates for BioCryst Pharmaceuticals’ earnings, with estimates ranging from $59.15 million to $66.95 million. BioCryst Pharmaceuticals posted sales of $49.96 million during the same quarter last […] ....
Equities research analysts expect BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Rating) to post ($0.36) earnings per share for the current quarter, Zacks reports. Five analysts have made estimates for BioCryst Pharmaceuticals’ earnings, with estimates ranging from ($0.48) to ($0.20). BioCryst Pharmaceuticals posted earnings per share of ($0.24) in the same quarter last year, which would […] ....